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Pancreaticobiliary maljunction (PBM) can be classified into two categories, PBM
with congenital biliary dilatation (CBD) or PBM without biliary dilatation, and
the management of PBM is often controversial. The treatment for PBM with CBD
is prophylactic flow diversion surgery, and some authors have reported that the
incidence of cancer after extrahepatic bile duct excision is less than 1%. A very
rare case of intrahepatic cholangiocarcinoma 6 years after flow diversion surgery
for PBM with CBD is reported.
CASE SUMMARY
A 30-year-old man was diagnosed as having PBM with CBD, Todani
classification type IVA, because of abnormal liver enzyme profiles. He underwent
flow diversion surgery and cholecystectomy, and the specimen showed
adenocarcinoma foci, pT1, pStage IA. Five and a half years passed without any
recurrence of bile duct cancer. However, 6 years after his operation, computed
tomography showed a gradually growing nodule in the bile duct.
Fluorodeoxyglucose positron emission tomography showed high uptake, and
magnetic resonance imaging showed restricted diffusion signals. On double
balloon enteroscopy, the nodule at the posterior bile duct-jejunum anastomosis
was directly visualized, and its biopsy specimen showed adenocarcinoma. The
patient underwent right lobectomy and biliary reconstruction. The pathological
diagnosis was intraductal papillary neoplasm with high-grade intraepithelial
neoplasia, pTis, pN0, pStage 0. The patient’s postoperative course was
uneventful, and he has had no recurrence up to the present time.
CONCLUSION
This case suggests the necessity of careful observation after flow diversion
surgery, especially when PBM with CBD is detected in adulthood.
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Core tip: Pancreaticobiliary maljunction (PBM) is one of the risk factors for biliary tract
cancer. A rare case of intrahepatic cholangiocarcinoma 6 years after flow diversion
surgery for PBM with congenital biliary dilatation (CBD) is presented. Careful follow-
up after flow diversion surgery is important to detect cholangiocarcinoma in its early
stage, especially when PBM with CBD is detected in adulthood, and when cancer has
already developed in the bile duct.
Citation: Ataka R, Ito T, Masui T, Seo S, Ishii T, Ogiso S, Yagi S, Taura K, Uemoto S.
Cholangiocarcinoma after flow diversion surgery for congenital biliary dilatation: A case




Pancreaticobiliary maljunction (PBM) is an uncommon congenital anomaly defined as
junction  of  the  pancreatic  and  bile  ducts  outside  the  duodenal  wall,  allowing
reciprocal reflux of pancreatic juice and bile, which is carcinogenic. Thus, PBM is a
high-risk  factor  for  biliary  tract  cancer,  and  preventive  surgery  is  necessary.
Congenital  biliary  dilatation  (CBD),  one  type  of  PBM,  is  usually  treated  with
prophylactic flow diversion surgery, and the extent of intrahepatic and extrahepatic
bile  duct  resection  is  often  controversial[1,2].  A  rare  case  of  a  young  man  who
developed cholangiocarcinoma 6 years after flow diversion surgery for PBM with
CBD is described.
CASE PRESENTATION
A  30-year-old  Japanese  man  was  found  to  have  liver  dysfunction  at  a  medical
examination. He had no remarkable medical history, was not on any medications, and
had no allergies to any food or drug. He visited a nearby hospital and was diagnosed
as  having  PBM  with  CBD.  His  common  bile  duct  showed  cystic  dilatation
accompanied by intrahepatic bile duct dilatation, which was classified as Todani type
IVA (Figure 1). In the same year, he underwent cholecystectomy and a flow diversion
operation that consisted of excision of the extrahepatic bile duct,  and biliary and
Roux-en-Y reconstruction. According to the Union for International Cancer Control
(UICC) 7th edition, the histopathological specimen showed adenocarcinoma foci, pT1,
pNx, pStage IA. He did not have any adjuvant chemotherapy and five and a half
years passed without any recurrence of biliary tract cancer.
MULTIDISCIPLINARY EXPERT CONSULTATION
However, six years after his operation, follow-up computed tomography (CT) showed
a gradually growing nodule,  about 10 mm in diameter,  at  the bile  duct-jejunum
anastomosis (Figure 2). Physical examination showed no abnormalities except for his
previous operative scar. Laboratory tests were unremarkable, including liver and
biliary enzyme profiles. Tumor markers were normal (carcinoembryonic antigen 0.8
ng/mL and carbohydrate 19-9 6.4 U/mL). Fluorodeoxyglucose positron emission
tomography (FDG-PET) showed high FDG uptake, and magnetic resonance imaging
showed restricted  diffusion  signals  at  the  same nodular  lesion.  Double  balloon
enteroscopy showed the lesion directly. There were four holes anastomoses at the
cholangiojejunostomy.  A  reddish  and  hemorrhagic  tumor  protruded  from  the
posterior hole, and the other three holes were intact; the biopsy specimen showed
adenocarcinoma (Figure 3).
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Figure 1
Figure 1  3D-reconstruction of magnetic resonance cholangiopancreatography shows an abnormally dilated
common bile duct (white star). Both right and left hepatic ducts also show intrahepatic dilatations (white arrows).
FINAL DIAGNSIS AND TREATMENT
One  month  after  percutaneous  transhepatic  portal  embolization  to  prevent
postoperative  liver  failure  due to  small  remnant  liver  volume less  than 30%,  he
underwent  right  lobectomy,  biliary  reconstruction,  and  regional  lymph  node
dissection. At laparotomy, there were severe adhesions due to his previous operation.
Right lobectomy was performed with dissection of the right hepatic artery, right
portal  vein,  right  hepatic  vein,  hilar  bile  ducts,  and  Roux-en-Y  jejunum  with
cholangiojejunostomy. The remaining bile ducts in the hilar plate were three holes of
B1,  B2  plus  B3,  and  B4.  The  biliary  reconstruction  was  performed  by  new
cholangiojejunostomy with a one-hole anastomosis. The Roux-en-Y reconstruction
was also performed by a new jejunojejunostomy. The histopathological diagnosis was
intraductal  papillary  neoplasm  of  the  bile  duct  with  high-grade  intraepithelial
neoplasia. There were no other abnormal findings in other intrahepatic bile ducts,
including the anterior and posterior branches, with a negative bile duct margin. The
dissected lymph nodes showed no evidence of malignancy. According to the UICC 8th
edition, the pTNM classification was pTis, pN0, pStage 0 (Figure 4).
OUTCOME AND FOLLOW-UP
The patient’s postoperative course was uneventful, and he was discharged on the 24th
postoperative day. There has been no evidence of re-recurrence up to the present
time.
DISCUSSION
PBM is a congenital anomaly defined as junction of the pancreatic and bile ducts
outside the duodenal wall. Because of the abnormally located junction, the sphincter
of  Oddi does not  work effectively.  Reciprocal  reflux of  pancreatic  juice  and bile
occurs, which introduces carcinogenic chemicals such as activated phospholipase A2
and secondary bile acids. These chemicals usually flow into the biliary tract because
the hydropressure in the pancreatic duct is greater than that in the bile duct. The
anomaly  can also  cause  chronic  cholangitis  and chronic  bacterbilia.  As  a  result,
patients with PBM have a higher risk of biliary tract cancer[3].
PBM can be divided into two categories: PBM with congenital biliary dilatation
(CBD), which was previously called congenital choledochal cyst; or PBM without
biliary dilatation (BD)[4]. Todani et al[5,6] classified this disease into five categories, and
the Todani classification is now commonly used worldwide.
The essential management of PBM is prophylactic surgery to avoid carcinogenesis,
and it should be performed immediately after the diagnosis of PBM[1]. Since bile stasis
in  the  dilated  biliary  tract  is  the  most  important  factor  for  the  development  of
WJH https://www.wjgnet.com November 27, 2019 Volume 11 Issue 11
Ataka R et al. Cholangiocarcinoma after flow diversion surgery
745
Figure 2
Figure 2  Abdominal CT images with contrast. A: Five and a half years after his first operation; B: Six years after his first operation. The images show a gradually
growing nodule with contrast over a half a year (yellow arrow).
malignant changes in biliary epithelial cells[7],  the treatment for PBM with CBD is
prophylactic flow diversion surgery, and that for PBM without BD is prophylactic
cholecystectomy. However, there is no consensus of opinion on whether intrahepatic
dilated bile ducts should be resected for PBM with CBD, or whether extrahepatic non-
dilated bile ducts should be resected for PBM without BD[1,8].
The present case showed a rare clinical course of PBM with CBD. Watanabe et al[9]
reported that the incidence of cancer after extrahepatic bile duct excision is less than
1%. There seem to be two reasons for the carcinogenesis in this case. The first reason is
that the flow diversion surgery left the dilated right hepatic duct in the hilar plate. In
the first operation, the dilated left hepatic duct was removed, but the dilated right
hepatic duct was used for cholangiojejunostomy. Since 30 years had passed before his
diagnosis of CBD, there must have been some histological  changes in the biliary
epithelial cells, such as hyperplasia, metaplasia, and dysplasia. Damage and repair of
the dilated biliary mucosa were likely to occur even after the first operation, resulting
in carcinogenesis at the site of the cholangiojejunostomy. The second reason is that the
reflux of intestinal juice at the cholangiojejunostomy probably played an important
role in carcinogenesis. The stasis of bile and intestinal juice in the dilated biliary tract
induces bacterial overgrowth and generation of unconjugated secondary bile acids[10].
The carcinogenic toxicity of  secondary bile  acids still  remains unclear,  but some
authors report  the following mechanism in mice and its  relationship to humans.
Secondary bile  acids suppress  the expression of  chemokine ligand 16 (CXCL16),
which recruits natural killer T cells, by liver sinusoidal endothelial cells. Then, the
suppressed expression of CXCL16 weakens immunological defenses and leads to the
development of malignancy and progression[11,12].
There  have been 41  reported cases  of  biliary  tract  cancer  after  flow diversion
surgery for PBM with CBD in the English literature from 1967 to 2016[7,13-41].  The
characteristics of these patients are shown below (Table 1). Of the 41 cases reported,
35 reported details of the interval between age at flow diversion surgery and age at
detection of biliary tract cancer. These 35 cases were divided into three groups by age
(A, child group, 0-15; B, adolescent/young adult group, 16-30; and C, adult group, >
30 years old), and the interval times are shown in the figure (Figure 5). There were
significant differences between Group A and Group B (median 26.5 vs 4.0 years, P <
0.0001), and between Group A and Group C (median 26.5 vs 8.5 years, P < 0.0001),
with no difference between Group B and Group C. These data mean that patients who
undergo flow diversion surgery in adulthood can develop biliary tract cancer earlier
than patients who undergo it in childhood. In adulthood, furthermore, interval time
does not always depend on age at flow diversion surgery, and it is short, most often
less  than  10  years.  This  fact  suggests  that  the  damage  to  the  remaining  biliary
epithelial  cells  due  to  carcinogenic  chemicals  is  greater  in  adulthood  than  in
childhood. In adulthood, the interval time may depend on the size of the dilated bile
duct, on the extent of reflux, on the flow diversion procedures, or on lifestyle. The
details remain unknown, and further similar cases need to be studied.
In  the  future,  the  current  patient  has  a  high  probability  of  re-recurrence  of
cholangiocarcinoma. Although Tsuchida et al[42] reported that chemoprevention can be
effective for PBM to prevent postoperative carcinogenesis, this is still controversial.
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Figure 3
Figure 3  Double balloon enteroscopy shows the cholangiojejunostomy directly. A: There are four-hole anastomoses: Anterior hole, posterior hole, B2 plus B3
hole, and B4 hole, from right to left. A reddish and hemorrhagic tumor protrudes from the posterior hole; B: The tumor extends inside the posterior branch.
CONCLUSION
Follow-up  throughout  the  life  of  a  patient  after  flow  diversion  surgery  is
recommended[4], but this is difficult in some cases. This case suggests the necessity of
careful observation after flow diversion surgery, especially when PBM with CBD is
detected in adulthood, and when cancer has already developed in the bile duct.
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Table 1  Characteristics of the patients with biliary tract cancer after flow diversion surgery




Todani classification I 16
IVA 16
NA 9
Age at flow diversion surgery1 28.3 (0-68)
NA 8
Age at detection of biliary tract cancer1 42.3 (20-70)
NA 8
Interval time1 12.6 (1-35)
NA 3
1Values are medians (range). NA: Not available.
Figure 4
Figure 4  Histological analysis of the tumor. A: Macroscopic findings; B: Hematoxylin and eosin (HE) staining, × 20; C: HE staining, ×400. Histological studies show
papillary growth and fibrovascular cores in the macroscopically nodular area (yellow arrow), comprising high-grade atypical epithelial cells. There is no invasive
carcinoma associated with the intraductal neoplasm.
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Figure 5
Figure 5  The graph shows the relationship between age at diversion surgery and interval time. Data represent means and standard deviation. P < 0.0001, one-
way analysis of variance and Bonferroni’s multiple comparison test.
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